|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Ablation techniques for primary and metastatic liver tumors显示文摘Ablative treatment methods have emerged as safe and effective therapies for patients with primary and secondary liver tumors who are not surgical candidates at the time of diagnosis.This article reviews the current literature and describes the techniques,complications and results for radiofrequency ablation,microwave ablation,cryoablation,and irreversible electroporation. | Michael J Ryan Jonathon Willatt Bill S Majdalany Ania Z Kielar Suzanne Chong Julie A Ruma Amit Pandya | 2016 | World Journal of Hepatology2016，8，3： | 13 |
| 2 | Radiofrequency ablation of pancreatic ductal adenocarcinoma:The past,the present and the future显示文摘Pancreatic ductal adenocarcinoma(PDAC)is one of the most aggressive cancers with a grim overall 5-year survival rate of 5%.Advances in surgical techniques,critical care,molecular diagnosis,diagnostic imaging,endosonology and adjuvant therapy have improved outcomes;but still more needs to be achieved.There is an urgent need to discover new avenues that may impact survival.Radiofrequency ablation(RFA)has attracted attention as an adjunctive treatment in PDAC.A review of English literature in Pub Med was done using the MESH terms for PDAC and RFA.All the articles were reviewed and core information was tabulated for reference.After a comprehensive review of all articles the data was evaluated to discover the role of RFA in PDAC management.Indications,contraindications,feasibility,success rate,safety,complications and impact on survival were reviewed and are discussed further.RFA appears to be an attractive option for nonmetastatic locally advanced PDAC.RFA is feasible but has a significant morbidity.At the present time the integration of RFA into the management of pancreatic ductal adenocarcinoma is evolving.It should be considered as having a complimentary role to current standard therapy in the multimodal management care model.It is likely that indications and patient selection for pancreatic RFA will expand. | Garvi J Pandya Vishal G Shelat | 2015 | World Journal of Gastrointestinal Oncology2015，7，2： | 5 |
| 3 | Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care显示文摘 | Katharine Bushby Richard Finkel David J Birnkrant Laura E Case Paula R Clemens Linda Cripe Ajay Kaul Kathi Kinnett Craig McDonald Shree Pandya James Poysky Frederic Shapiro Jean Tomezsko Carolyn Constantin | 2010 | Lancet Neurology2010，，2： | 1 |
| 4 | The human papillomavirus (HPV) 16, E2 protein induces apoptosis in the absence of other HPV proteins and via a p53-dependent pathway显示文摘 | Webster K Parish J Pandya M | 2000 | J Biol Chemistry2000，275，1： | 1 |
| 5 | Prevalence of gout and hyperu-ricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008显示文摘 | ZHU Y PANDYA B J CHOI HK | 2011 | Arthri- tis&Peumatism2011，63，： | 1 |
| 6 | Prevalence of gout and hyperuricemia in the US general population:the National Health and Nutrition Examination Survey 2007-2008 显示文摘 | Zhu Y Pandya B J Choi H K | 2011 | Arthritis Rheum2011，63，10： | 1 |
| 7 | Toxicity profile and pharmacokinetic study of a phase Ilow-dose schedule-dependent radiosensitizing paclitaxelchemoradiation regimen for inoperable non-small ceillung cancer (NSCLC)显示文摘 | Yuhchyau Chen Kishan J Pandya Richard Feins | 2008 | Int J Radiat Oncol Biol Phys2008，71，2： | 1 |
| 8 | Megestrol and tamoxifenin patients with advanced endometrial cancer : an Eastern Cooperative Oncology Group Study (E4882) 显示文摘 | Yeap B Y Weincr L M | 2001 | Am J Clin Oncol2001，24，1： | 1 |
| 9 | A vaccine candidatefor eastern equine encephalitis virus based on IRES-mediatedattenuation显示文摘 | Pandya J Gorchakov R Wang E | 2012 | Vaccine2012，30，7： | 1 |
| 10 | The human papillolnavirus(HPV) 16 E2 protein induces apoptosis in the absence of other HVP proteins and via a p53-dependent pathway显示文摘 | Webster K Parish J Pandya M | 2000 | J Biol Chem2000，275，： | 1 |
| 11 | Eastern cooperative oncology group randomized trials of observation versus maintenance therapy for patients with metastatic breast cancer in complete remission following induction treatment显示文摘 | Falkson G Gelman R S Pandya K J | 1998 | J Clin Oneol1998，16，5： | 1 |
| 12 | Measurement of cohesive zone parameters in tough polyethylene 显示文摘 | Pandya K C Williams J G | 2000 | Polymer Engineering and Science2000，40，8： | 1 |
| 13 | Prevention of chemotherapy induced nausea and vomiting: a focus on aprepitant显示文摘 | Sankhala KK Pandya DM Sarantopoulos J | 2009 | Expert Opin Drug Metab Toxicol2009，5，12： | 1 |
| 14 | Comorbidities of gour and hyperuricemia in ths US general population: NHANES 2007-2008 显示文摘 | Zhu Y Pandya B J Choi HK | 2012 | Am J Med2012，125，： | 1 |
| 15 | Comorbidities of gout and hyperuricemia in the US general population:NHANES2007-2008显示文摘 | Zhu Y Pandya B J Choi H K | 2012 | Am J Med2012，125，7： | 1 |
| 16 | Oral clonidine in post-menopausal patients with breast cancer experiencing tamoxifen-induced hot flashes: a University of Rochester Cancer Center Community Clinical Oncology Program Study显示文摘 | Pandya K J Raubertas RF Flynn PJ | 2000 | Ann Intern Med2000，132，10： | 1 |
| 17 | Diesel exhaust and asthma: hy- potheses and molecular mechanisms of action 显示文摘 | Robert J Pandya GS Amy K | 2002 | Environ Health Perspect2002，110，1： | 1 |
| 18 | Prevalence of gout and hyperuricemia in the US general population:the National Health and Nutrition Examination Survey 2007-2008显示文摘 | ZHU Y PANDYA B J CHOI H K | | 0，，10： | 1 |
| 19 | Prevalence of gout and hype- ruricemia in the US general population: The National Health and Nutrition Examination Survey 2007 - 2008 显示文摘 | ZHU PANDYA B J CHOI H K | 2011 | Arthritis Rheum2011，63，10： | 1 |
| 20 | A preliminary report of a double blind placebo controlled trial of gabapentin for control of hot fashes in women with breast cancer : a University of Roches- ter Cancer Center CCOP study显示文摘 | Pandya K J Roscoe J Pajon E | 2004 | ASCO Annual Meeting Proceedings ( Post-Meeting Edition)2004，22，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员